Syntaxin 6: A novel predictive and prognostic biomarker in papillary renal cell carcinoma
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Syntaxin 6: A novel predictive and prognostic biomarker in papillary renal cell carcinoma
Authors
Keywords
-
Journal
Scientific Reports
Volume 9, Issue 1, Pages -
Publisher
Springer Nature
Online
2019-02-28
DOI
10.1038/s41598-019-39305-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- γ-Tocotrienol-induced disruption of lipid rafts in human breast cancer cells is associated with a reduction in exosome heregulin content
- (2017) Osama A. Alawin et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Lipids in exosomes: Current knowledge and the way forward
- (2017) Tore Skotland et al. PROGRESS IN LIPID RESEARCH
- UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
- (2017) Darshan S. Chandrashekar et al. NEOPLASIA
- Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial
- (2016) Naomi B Haas et al. LANCET
- PGE2 /EP4 Signaling Controls the Transfer of the Mammary Stem Cell State by Lipid Rafts in Extracellular Vesicles
- (2016) Meng-Chieh Lin et al. STEM CELLS
- Systemic therapy in metastatic renal cell carcinoma
- (2016) Jens Bedke et al. WORLD JOURNAL OF UROLOGY
- A phase I study of cabozantinib (XL184) in patients with renal cell cancer
- (2014) T. K. Choueiri et al. ANNALS OF ONCOLOGY
- Biophysics of cell membrane lipids in cancer drug resistance: Implications for drug transport and drug delivery with nanoparticles
- (2013) Chiranjeevi Peetla et al. ADVANCED DRUG DELIVERY REVIEWS
- Improved overall survival after implementation of targeted therapy for patients with metastatic renal cell carcinoma: Results from the Danish Renal Cancer Group (DARENCA) study-2
- (2013) Anne V. Soerensen et al. EUROPEAN JOURNAL OF CANCER
- Regulation of integrin endocytic recycling and chemotactic cell migration by syntaxin 6 and VAMP3 interaction
- (2012) K. A. Riggs et al. JOURNAL OF CELL SCIENCE
- Phase II and Biomarker Study of the Dual MET/VEGFR2 Inhibitor Foretinib in Patients With Papillary Renal Cell Carcinoma
- (2012) Toni K. Choueiri et al. JOURNAL OF CLINICAL ONCOLOGY
- The metabolic basis of kidney cancer
- (2012) W. Marston Linehan et al. SEMINARS IN CANCER BIOLOGY
- Histologic Variants of Renal Cell Carcinoma: Does Tumor Type Influence Outcome?
- (2012) Fang-Ming Deng et al. UROLOGIC CLINICS OF NORTH AMERICA
- Regulation of vascular endothelial growth factor receptor 2 trafficking and angiogenesis by Golgi localized t-SNARE syntaxin 6
- (2010) V. Manickam et al. BLOOD
- p53 and MDM2 in renal cell carcinoma
- (2010) Aidan P. Noon et al. CANCER
- Drug Resistance in Breast Cancer Cells: Biophysical Characterization of and Doxorubicin Interactions with Membrane Lipids
- (2010) Chiranjeevi Peetla et al. MOLECULAR PHARMACEUTICS
- Cytogenetic and Molecular Tumor Profiling for Type 1 and Type 2 Papillary Renal Cell Carcinoma
- (2009) T. Klatte et al. CLINICAL CANCER RESEARCH
- VEGF, COX-2, and PCNA expression in renal cell carcinoma subtypes and their prognostic value
- (2008) Ayhan Dirim et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Syntaxin 6, a Regulator of the Protein Trafficking Machinery and a Target of the p53 Family, Is Required for Cell Adhesion and Survival
- (2008) Yanhong Zhang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Transport of LDL-derived cholesterol from the NPC1 compartment to the ER involves the trans-Golgi network and the SNARE protein complex
- (2008) Y. Urano et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started